Home/Filings/4/0000899243-22-014108
4//SEC Filing

Versant Voyageurs I, L.P. 4

Accession 0000899243-22-014108

CIK 0001435049other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:38 PM ET

Size

21.9 KB

Accession

0000899243-22-014108

Insider Transaction Report

Form 4
Period: 2022-04-04
Transactions
  • Other

    Common Stock

    2022-04-04+14,19414,194 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-04709,9532,913,070 total
  • Other

    Common Stock

    2022-04-0414,1940 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-04+11,72611,726 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-0411,7260 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    552,149
  • Common Stock

    (indirect: See Footnote)
    1,863,197
Transactions
  • Other

    Common Stock

    2022-04-04709,9532,913,070 total
  • Other

    Common Stock

    2022-04-04+14,19414,194 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-0414,1940 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-04+11,72611,726 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-0411,7260 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,863,197
  • Common Stock

    (indirect: See Footnote)
    552,149
Transactions
  • Other

    Common Stock

    2022-04-04709,9532,913,070 total
  • Other

    Common Stock

    2022-04-04+14,19414,194 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-0414,1940 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-04+11,72611,726 total(indirect: See Footnote)
  • Other

    Common Stock

    2022-04-0411,7260 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,863,197
  • Common Stock

    (indirect: See Footnote)
    552,149
Footnotes (10)
  • [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VII, L.P. ("Versant VII") to its partners pursuant to a Rule 10b5-1 trading plan.
  • [F10]These securities are held of record by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel"). Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant Voyageurs I GP. Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP, Versant Voyageurs I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant I Parallel, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F2]These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. ("Versant Ventures VII GP") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC ("Versant Ventures VII GP-GP") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant Ventures VII GP-GP, Versant Ventures VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F3]Represents a change in the form of ownership of Versant Ventures VII GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VII.
  • [F4]Shares held by Versant Ventures VII GP. Versant Ventures VII GP-GP is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP. Each of Versant Ventures VII GP-GP and Jerel C. Davis disclaim beneficial ownership of the shares held by Versant Ventures VII GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP to its partners.
  • [F6]Represents a change in the form of ownership of Versant Ventures VII GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VII GP.
  • [F7]Shares held by Versant Ventures VII GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP-GP. Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Ventures VII GP-GP, except to the extent of his pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F8]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP-GP to its members.
  • [F9]These securities are held of record by Versant Voyageurs I, L.P. ("Versant Voyageurs I"). Versant Voyageurs I GP Company is the general partner of Versant Voyageurs I. Jerel C. Davis, a member of the Issuer's board of directors, is a director of Versant Voyageurs I GP Company and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I. Each of Versant Voyageurs I GP Company and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Voyageurs I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports.

Issuer

CHINOOK THERAPEUTICS, INC.

CIK 0001435049

Entity typeother
IncorporatedOntario, Canada

Related Parties

1
  • filerCIK 0001745960

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:38 PM ET
Size
21.9 KB